US FDA Gives Wholesalers But Not Manufacturers More Time To Begin Verifying Saleable Returns
Manufacturers Must Still Respond To Verification Requests Within 24 Hours
Executive Summary
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
You may also be interested in...
US FDA: Pharmaceutical Distribution Entering DSCSA Compliance ‘Stabilization Period’
Agency officials advise drug supply chain partners what stabilization activities they expect to see during one-year “enforcement discretion” period; industry lawyers advise that anyone found coasting could face discretionary enforcement. More discretion, more guidance in the works, including a final ruling on state preemption.
Lack Of Readiness In Responding To DSCSA Verification Requests Major Concern
Roughly half of all pharmaceutical manufacturers have misgivings they will have the necessary systems to electronically verify saleable returns under DSCSA, even though they must respond to these requests within 24 hours.
COVID-19 Could Offer Some DSCSA Enforcement Relief For Manufacturers
As the US FDA focuses on COVID-19 pandemic-related activities, the time may be right to ask for an extension in complying with the DSCSA’s saleable returns verification deadline.